146 related articles for article (PubMed ID: 11013361)
1. Avascular necrosis of the femoral head in chronic myeloid leukemia patients treated with interferon-alpha: a synergistic correlation?
Kozuch P; Talpaz M; Faderl S; O'Brien S; Freireich EJ; Kantarjian H
Cancer; 2000 Oct; 89(7):1482-9. PubMed ID: 11013361
[TBL] [Abstract][Full Text] [Related]
2. Avascular necrosis in patients with chronic myeloid leukemia: A systematic review.
Yassin M; Al-Mashdali AF; Al-Dubai HN
Acta Biomed; 2022 Mar; 93(1):e2022017. PubMed ID: 35315390
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
4. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
[TBL] [Abstract][Full Text] [Related]
5. A case of avascular necrosis of the femoral head as initial presentation of chronic myelogenous leukemia.
Moon JY; Kim BS; Yun HR; Choi JH; Lee YY; Kim IS; Ahn MJ
Korean J Intern Med; 2005 Sep; 20(3):255-9. PubMed ID: 16295787
[TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukemia presenting with avascular necrosis of femur head.
Gupta D; Gaiha M; Siddaraju N; Daga MK; Anuradha S
J Assoc Physicians India; 2003 Feb; 51():214-5. PubMed ID: 12725271
[TBL] [Abstract][Full Text] [Related]
7. Avascular necrosis of femoral head as the initial manifestation of CML.
Kumar S; Bansal D; Prakash M; Sharma P
Pediatr Hematol Oncol; 2014 Sep; 31(6):568-73. PubMed ID: 24087840
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
[TBL] [Abstract][Full Text] [Related]
9. Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report.
Ozet A; Ozet G; Calişkaner Z; Kömürcü S; Oztürk B
Endocr J; 1997 Oct; 44(5):715-7. PubMed ID: 9466328
[TBL] [Abstract][Full Text] [Related]
10. Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia.
Tannir NM; Talpaz M; Ghazal H; Proothi S; Kantarjian HM
Leuk Lymphoma; 2000 Nov; 39(5-6):647-50. PubMed ID: 11342349
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
Chim CS; Ma SK; Lam CK
Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.
Rachmani R; Avigdor A; Youkla M; Raanani P; Zilber M; Ravid M; Ben-Bassat I
Acta Haematol; 1998; 100(4):204-6. PubMed ID: 9973644
[TBL] [Abstract][Full Text] [Related]
14. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
Song YQ; Li W; Kong LH; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
[TBL] [Abstract][Full Text] [Related]
15. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
Kujawski LA; Talpaz M
Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986
[TBL] [Abstract][Full Text] [Related]
16. Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.
Tóthová E; Fricová M; Kafková A; Stecová N; Guman T; Raffac S; Hlebasková M
Neoplasma; 2000; 47(2):125-8. PubMed ID: 10985480
[TBL] [Abstract][Full Text] [Related]
17. Targeted chronic myeloid leukemia therapy: Seeking a cure.
Fausel C
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S9-15. PubMed ID: 18056932
[TBL] [Abstract][Full Text] [Related]
18. Avascular necrosis of the femoral head following trochanteric fractures in adults: a systematic review.
Barquet A; Mayora G; Guimaraes JM; Suárez R; Giannoudis PV
Injury; 2014 Dec; 45(12):1848-58. PubMed ID: 25467713
[TBL] [Abstract][Full Text] [Related]
19. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M
Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
